Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2024 (1)
  • 2023 (1)
  • 2021 (1)
  • 2019 (1)
  • 2018 (2)

Subject

  • Arrests/Convictions - Major (1)
  • Diversion Division (1)
  • Pharmaceuticals/Pharmacists/Physicians (1)
  • Prescription Drugs (1)

Drug Name

  • Methamphetamine (28)
  • Fentanyl (24)
  • Cocaine (12)
  • Heroin (7)
  • Synthetic Opioids (4)
  • Marijuana (Cannabis) (3)
  • Ecstasy/MDMA (1)
  • Methadone (1)
  • Oxycodone (6)
  • Ketamine (0)

Field Division

  • New England (66)
  • Atlanta (50)
  • New York (37)
  • Washington, DC (24)
  • Miami (19)
  • San Francisco (17)
  • Seattle (17)
  • St. Louis (16)
  • Chicago (8)
  • New Jersey (6)
  • Sede (6)
  • Dallas (5)
  • Houston (5)
  • Rocky Mountain (4)
  • El Paso (2)
  • Detroit (1)
  • Los Angeles (1)
  • Omaha (1)
  • Phoenix (1)
  • San Diego (1)
  • New Orleans (6)
Clear All Results
6 Results - Showing 1 to 6
PRESS RELEASE

Former Doctor and Her Wife Sentenced for Fraud and Other Crimes

HUNTSVILLE, Ala. – A former family practice doctor in Huntsville was sentenced today for drug crimes, health care fraud, and COVID-19 disaster relief fraud, announced U.S. Attorney Prim F. Escalona, FBI Special Agent in Charge Carlton Peeples, Drug Enforcement Administration Special Agent in Charge Steven L. Hofer, and Special Agent...
PRESS RELEASE

Former Gadsden Pharmacist and City School Board Member Sentenced for Drug Distribution Conspiracy and Tax Crimes

BIRMINGHAM, Ala. – A former Gadsden-area pharmacist and city school board member was sentenced yesterday for drug distribution conspiracy and tax crimes, announced U.S. Attorney Prim F. Escalona, Federal Bureau of Investigation Special Agent in Charge Carlton L. Peeples, Drug Enforcement Administration Special Agent in Charge Brad L. Byerley, and...
PRESS RELEASE

DEA Issues Warning Over Counterfeit Pills

NEW ORLEANS – DEA is alerting all citizens to an increase in drug overdose deaths tied to counterfeit pills containing the powerful synthetic opioid fentanyl. Manufactured by Mexican drug trafficking (DTOs), and marketed as a medication such as oxycodone on the illicit drug market, these pills can be deadly. One...
PRESS RELEASE

DEA and U.S. Attorney in the Western District of Louisiana announce settlement with drug distributor

NEW ORLEANS – Morris & Dickson Company LLC has agreed to pay the United States $22 million in civil penalties to resolve claims that it violated the Controlled Substances Act by failing to report suspicious orders of hydrocodone and oxycodone, announced Drug Enforcement Administration Special Agent in Charge Brad L...
PRESS RELEASE

Montgomery Nurse Practitioner convicted of unlawfully distributing controlled substances, health care fraud, and conspiracy

MONTGOMERY, Ala. – On Monday, Oct. 29, 2018, a federal jury convicted nurse practitioner Lilian Ifeoma Akwuba, 39, of Montgomery, Alabama, on 17 counts of unlawfully distributing controlled substances, 4 counts of health care fraud, 1 count of conspiring to distribute controlled substances, and 1 count of conspiring to commit...
PRESS RELEASE

New Orleans-area defendants plead guilty to fraudulent possession and black market distribution of oxycodone

NEW ORLEANS – Eight New Orleans-area defendants have pleaded guilty for their participation in a conspiracy to obtain oxycodone through fraud by using fictitious prescriptions. Six of the eight defendants have also pleaded guilty for their roles in a scheme to possess with intent to distribute oxycodone on the black...
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster